AzTrials
AzTrials

Urinary IncontinenceNCT07669922

Urban-Rural Comparison of Urinary Incontinence Impact in Women

An observational study of Urinary Incontinence, run by Lokman Hekim University at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study will examine how urinary incontinence affects women's daily activities and quality of life in urban and rural areas. Urinary incontinence means unintentional urine leakage. It may affect activities such as exercise, household tasks, social participation, travel, emotional well-being, and daily routines. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Urinary Incontinence
What is being tested?
Observational assessment
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2026to 1 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The study population will consist of self-identified women aged 18 to 65 years living in urban or rural areas who have experienced urinary incontinence within the previous 3 months. Participants will be recruited on a voluntary basis through direct contact, announcements, and snowball sampling. Women living in urban and rural areas will be enrolled in separate cohorts, with a planned total sample size of 100 participants (50 urban and 50 rural).

Who may be able to join

  • Women aged 18 to 65 years.
  • Reported urinary incontinence, including any amount of involuntary urine leakage, within the previous 3 months, as determined by the Three Incontinence Questions.
  • Able to understand and complete the study questionnaires.
  • Provided written informed consent.

Who cannot join

  • Currently receiving medical, surgical, or conservative treatment for urinary incontinence.
  • Use of a urinary catheter or indwelling urinary device.
  • Communication, cognitive, or cooperation problems that prevent completion of the questionnaires.
  • Diagnosis of a neurological or chronic condition that may cause urinary incontinence, including multiple sclerosis, spinal cord injury, Alzheimer disease, or Parkinson disease.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Lokman Hekim University, Ankara, Ankara

    Ankara, Ankara, 06510

Other trials in Turkey (Türkiye)

About this study

Official title: Impact of Urinary Incontinence on Quality of Life and Daily Activities in Women: A Cross-Sectional Comparison Between Urban and Rural Areas

This study will examine how urinary incontinence affects women's daily activities and quality of life in urban and rural areas. Urinary incontinence means unintentional urine leakage. It may affect activities such as exercise, household tasks, social participation, travel, emotional well-being, and daily routines.

Women aged 18 to 65 years who have experienced urinary incontinence during the past 3 months may be eligible to participate. Participants will complete questionnaires about their health, urinary symptoms, severity of urine leakage, daily activities, and quality of life. The assessment is expected to take approximately 20 minutes.

This is an observational study. No medication, exercise program, medical procedure, or other treatment will be provided. The study will compare questionnaire results between women living in urban and rural areas. The findings may help improve understanding of how living environment and personal factors are associated with the impact of urinary incontinence.

Read the detailed description

Urinary incontinence is the involuntary leakage of urine and may negatively affect women's physical activities, household responsibilities, social participation, emotional well-being, and overall quality of life. The perceived impact of urinary incontinence may vary according to living environment, access to health services, socioeconomic conditions, cultural attitudes, and daily life demands.

This cross-sectional observational study aims to compare urinary incontinence severity, urinary incontinence-related quality of life, and the impact of urinary incontinence on daily activities among women living in urban and rural areas.

Women aged 18 to 65 years who report urinary incontinence within the previous 3 months will be recruited voluntarily. Participants currently receiving medical, surgical, or conservative treatment for urinary incontinence; using a urinary catheter; having communication or cooperation problems that prevent questionnaire completion; or having neurological conditions that may cause urinary incontinence will not be included.

Eligible participants will complete a sociodemographic information form, the Three Incontinence Questions, the Incontinence Severity Index, the International Consultation on Incontinence Questionnaire-Short Form, the Incontinence Impact Questionnaire-7, and the Incontinence Quality of Life Questionnaire. Data will be collected face-to-face in a private setting. No intervention, treatment, medication, exercise program, or invasive procedure will be administered.

The primary purpose is to determine whether urinary incontinence severity and its effects on daily activities and quality of life differ between women living in urban and rural areas. The study will also examine the relationship between urinary incontinence-related outcomes and sociodemographic factors, including age, education level, employment status, body mass index, chronic disease status, birth history, delivery type, income level, and menopausal status.

Being tested
Observational assessment
Keywords
Urinary Incontinence, Women's Health, Quality of Life, Urban Population, Rural Population
Medical subject headings
Urinary Incontinence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Observational assessmentOther

    Participants completed assessment forms and diaries. No intervention was administered.

Study groups in NCT07669922
Study groupRoleWhat they receive
Urban Women With Urinary IncontinenceWomen aged 18 to 65 years who live in urban areas and report urinary incontinence within the previous 3 months. Participants will complete questionnaires assessing urinary incontinence severity, urinary symptom impact, daily activities, quality of life, and sociodemographic characteristics. No intervention or treatment will be administered.
Receives: Other: Observational assessment
Rural Women With Urinary IncontinenceWomen aged 18 to 65 years who live in rural areas and report urinary incontinence within the previous 3 months. Participants will complete questionnaires assessing urinary incontinence severity, urinary symptom impact, daily activities, quality of life, and sociodemographic characteristics. No intervention or treatment will be administered.
Receives: Other: Observational assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urinary Incontinence Severity Assessed by the Incontinence Severity Index

    Urinary incontinence severity will be assessed using the Incontinence Severity Index. The score is calculated by multiplying the frequency of urinary leakage by the amount of urine leakage. Scores range from 1 to 12 and are categorized as mild (1-2), moderate (3-6), severe (8-9), or very severe (12). Higher scores indicate greater urinary incontinence severity.

    Measured: Baseline (Day 1)

  2. Impact of Urinary Incontinence on Daily Activities Assessed by the Incontinence Impact Questionnaire-7

    The impact of urinary incontinence on daily activities will be assessed using the Incontinence Impact Questionnaire-7. The questionnaire evaluates the effect of urinary incontinence on household tasks, physical activities, social activities, travel, and emotional well-being. Scores are converted to a 0 to 100 scale. Higher scores indicate a greater negative impact of urinary incontinence on daily activities.

    Measured: Baseline (Day 1)

  3. Urinary Incontinence-Related Quality of Life Assessed by the Incontinence Quality of Life Questionnaire

    Urinary incontinence-related quality of life will be assessed using the Incontinence Quality of Life Questionnaire. The questionnaire includes 22 items scored on a 5-point Likert scale. Scores are transformed to a 0 to 100 scale. Higher scores indicate better urinary incontinence-related quality of life.

    Measured: Baseline (Day 1)

Secondary outcomes (2)
  1. Urinary Incontinence Symptom Severity and Impact Assessed by the International Consultation on Incontinence Questionnaire-Short Form

    Urinary incontinence symptom severity and perceived impact on daily life will be assessed using the International Consultation on Incontinence Questionnaire-Short Form. The total score ranges from 0 to 21 and is calculated from urinary leakage frequency, amount of leakage, and perceived impact on daily life. Higher scores indicate greater symptom severity and greater impact on quality of life.

    Measured: Baseline (Day 1)

  2. Association of Sociodemographic and Clinical Characteristics With Urinary Incontinence Outcomes

    Sociodemographic and clinical characteristics, including age, body mass index, education level, employment status, income level, chronic disease status, birth history, delivery type, and menopausal status, will be recorded and examined in relation to urinary incontinence severity, daily activity impact, and quality of life.

    Measured: Baseline (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2026
  2. Study start1 Jan 2026
  3. Primary completion1 Jun 2026
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07669922
Sponsor's protocol ID
2025355
Status last verified
Jan 2026
First submitted
21 Jun 2026
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Urinary Incontinence, run by Lokman Hekim University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urinary Incontinence Severity Assessed by the Incontinence Severity Index (time frame: Baseline (Day 1)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in